(1)
Brought to Australia and New Zealand in Partnership with AI Advance, Mia is the First and Only AI-Enabled Independent Reader for Breast Cancer Screening to Receive Clearance in Each Country
Marking a new milestone for artificial intelligence (AI) adoption in the Australian and New Zealand breast screening community, the Mia solution, created by United Kingdom-based Kheiron Medical Technologies, received Therapeutic Goods Administration (TGA) clearance from the Australian Government Department of Health and MedSafe WAND Notification from the New Zealand Ministry of Health as an AI-enabled independent reader for the early detection and diagnosis of breast cancer. Mia is being launched in partnership with AI Advance, an AI consulting services and software distribution company for the medical imaging industry based in Australia and New Zealand.